Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

New cooling caps can help prevent hair loss from chemotherapy in a cost-effective and eco-friendly way.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Intravenous arsenic is safe and effective for treating certain blood cancers.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Scalp cooling can effectively reduce hair loss during chemotherapy, with modern methods improving comfort and accessibility.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.